EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study

Samuel Frey iD, Christelle Volteau, Hélène Lasolle, Cécile Caillard, Delphine Drui, Sabine Pattier, Françoise Borson-Chazot, Laure Maillard, Jean-Christophe Lifante, Eric Mirallié

European Thyroid Journal · 2026

DOI: 10.1530/etj-25-0292 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Thyroid Journal, 2026. Verfasst von Samuel Frey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Nantes, France. Hauptthemen laut MEDLINE: Thyrotoxicosis, Amiodarone, Thyroidectomy, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Amiodarone-induced thyrotoxicosis (AIT) affects 5–10% of patients on amiodarone therapy, increasing cardiovascular (CV) risk. Total thyroidectomy is proposed for refractory cases, but its long-term impact on major adverse cardiovascular events (MACEs) remains uncertain. This study evaluates post-operative MACEs and cardiac mortality in AIT patients with and without pre-operative left ventricular ejection fraction (LVEF) impairment.

Methods

Patients undergoing total thyroidectomy for AIT from 2010 to 2023 in two French referral centers were retrospectively included. They were divided into two groups based on pre-operative LVEF (<40% vs ≥40%). The main outcomes were the post-operative MACEs and cardiac mortality at one and five years.

Results

Among 101 patients, 26 had LVEF < 40% (group 1), while 75 had LVEF ≥ 40% (group 2). Patients in group 1 were younger, had higher ASA (American Society of Anesthesia) scores, and had more severe cardiac conditions. The median duration of exposure to AIT was 2.7 (Q1; Q3 1.3; 4.7) months. Overall, perioperative mortality was 2.0%. Group 1 showed higher 5-year MACE occurrence (61.4 vs 24.0%, P = 0.0005) and higher cardiac mortality (30.8 vs 1.3%, P = 0.0001). Multivariate regression identified younger age at AIT diagnosis and baseline LVEF < 40% as significantly associated with a higher 5-year MACE rate. Among patients with baseline LVEF < 40%, those with early post-operative LVEF improvement displayed a lower rate of 5-year MACEs (47.1 vs 100%, P = 0.022).

Conclusion

Patients with LVEF < 40% carries a high long-term CV risk despite early thyroidectomy. Post-operative LVEF assessment may help identify high-risk patients. In contrast, those with LVEF ≥ 40% have a favorable prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyrotoxicosisAmiodaroneThyroidectomyCardiovascular DiseasesAnti-Arrhythmia AgentsHumansFemaleRetrospective StudiesMaleMiddle AgedAgedAdultStroke VolumePostoperative ComplicationsVentricular Function, Left

Stichwörter der Autor:innen

amiodaronecardiovascular riskthyoidectomythyrotoxicosis

Substanzen

AmiodaroneAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Nantes Université, CHU Nantes, Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Nantes, France.
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
  • Nantes Université, CHU Nantes, DRCI, Département Promotion, Nantes, France.
  • Service d'endocrinologie, Hôpital Louis-Pradel, Hospices civils de Lyon, Lyon, France.
  • Nantes Université, CHU Nantes, Service d'Endocrinologie, Diabétologie et Nutrition, l'institut du thorax, Nantes, France.
  • Nantes Université, CHU Nantes, Service de cardiologie, Hôpital Nord Laennec, Nantes, France.

ORCID-Profile: Samuel Frey

Zitieren

APA

Frey, S., Volteau, C., Lasolle, H., Caillard, C., Drui, D., Pattier, S., Borson-Chazot, F., Maillard, L., Lifante, J. C., & Mirallié, E. (2026). Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study. European Thyroid Journal. https://doi.org/10.1530/etj-25-0292

Vancouver

Frey S, Volteau C, Lasolle H, Caillard C, Drui D, Pattier S, et al. Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study. European Thyroid Journal. 2026. doi:10.1530/etj-25-0292

BibTeX
@article{Frey2026,
  author = {Frey, Samuel and Volteau, Christelle and Lasolle, Hélène and Caillard, Cécile and Drui, Delphine and Pattier, Sabine and Borson-Chazot, Françoise and Maillard, Laure and Lifante, Jean-Christophe and Mirallié, Eric},
  title = {Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study},
  journal = {European Thyroid Journal},
  year = {2026},
  doi = {10.1530/etj-25-0292}
}
Kostenlos starten →